Fredun Pharmaceuticals Quarterly Results for Trading Insights

FREDUN • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹9 Cr
QSept 2025
Quarterly Results

Fredun Pharmaceuticals Quarterly Results Key Highlights

  • Revenue of ₹144 Cr in Sept 2025 (-12.7% vs Mar 2025)
  • Net Profit of ₹9 Cr in Sept 2025 (+50.0% vs Mar 2025)
  • EBITDA of ₹21 Cr in Sept 2025 (+40.0% vs Mar 2025)
  • Operating Margin of 14.0% in Sept 2025 (+5.0pp vs Mar 2025)
  • Earnings Per Share of ₹19.98 in Sept 2025 (+57.2% vs Mar 2025)

Fredun Pharmaceuticals Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Jun 2024 QoQ YoY
Revenue (₹ Cr) 144 165 119 0 0 -12.7% -
Net Profit (₹ Cr) 9 6 7 0 0 - -
EBITDA (₹ Cr) 21 15 17 0 0 - -
EPS (₹) 19.98 12.71 14.33 0.00 0.00 - -
Operating Margin (%) 14.0% 9.0% 14.0% 0.0% 0.0% - -

Fredun Pharmaceuticals Share Price Trend Around Quarterly Results

Visualize Fredun Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Fredun Pharmaceuticals

Additional stock information and data for FREDUN

Fredun Pharmaceuticals stock price NSE
FREDUN earnings valuation
Fredun Pharmaceuticals 52-week

Profitability Ratios

Profit Margin 6.3%
EBITDA Margin 14.6%
Operating Margin 14.0%
ROE (Annual) 25.5%

Balance Sheet Highlights

Total Assets ₹487 Cr
Total Equity ₹141 Cr
Current Assets ₹428 Cr
Current Liabilities ₹18 Cr

Cash Flow Analysis

Operating Cash Flow ₹0 Cr
Investing Cash Flow ₹-8 Cr
Financing Cash Flow ₹6 Cr
Net Cash Flow ₹-2 Cr

Current Market Data

Current Price ₹1671.80
Exchange BSE
Last Updated Mar 30, 2026

Revenue Trend (₹ Cr)

Sept 2024 0
Jun 2025 119
Mar 2025 165
Sept 2025 144

Net Profit Trend (₹ Cr)

Sept 2024 0
Jun 2025 7
Mar 2025 6
Sept 2025 9

Operating Margin Trend (%)

Sept 2024 0.0%
Jun 2025 14.0%
Mar 2025 9.0%
Sept 2025 14.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Fredun Pharmaceuticals quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹430,344.72 Cr 1757.2 14,875 3,125 +10.8% - 21.0% 135.2
Divis Laboratories
Sept 2025 		₹159,214.78 Cr 5947.0 2,860 689 +7.1% - 24.1% 229.0
Torrent Pharmaceuti…
Sept 2025 		₹144,367.29 Cr 4220.2 3,219 591 +11.3% - 18.4% 240.6
Lupin
Sept 2025 		₹107,238.09 Cr 2313.9 6,921 1,485 +23.2% - 21.5% 71.5
Dr Reddys Laborator…
Sept 2025 		₹106,974.57 Cr 1254.9 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores